Back
#1
24.0%
Top 35%
19.1%
Top 0.2%
15.8%
Top 1.0%
6.4%
Top 37%
4.2%
Top 2%
2.1%
Top 5%
2.1%
Top 78%
2.1%
Top 11%
2.1%
Top 12%
1.4%
Top 4%
1.0%
Top 9%
1.0%
Top 19%
0.8%
Top 32%
0.8%
A Double-Blind, Randomized, Controlled Phase III Trial Investigating Efficacy and Safety of Varenicline for Vaping Cessation in Adult Users
2022-12-20
addiction medicine
Title + abstract only
View on medRxiv
Show abstract
BackgroundVaping cessation is virtually unexplored. The efficacy and safety of varenicline for vaping cessation has not been studied and rigorous research is required to advance best practice and outcomes for e-cigarettes users who want to quit. MethodsEligible patients were randomized to either varenicline (1 mg, administered twice daily for 12 weeks) or placebo treatment (administered twice daily, for 12 weeks) combined with vaping cessation counseling. The trial consisted of a 12-week treatm...
Predicted journal destinations
1
Addiction
24 training papers
2
PLOS ONE
1737 training papers
3
Drug and Alcohol Dependence
21 training papers
4
JAMA Network Open
125 training papers
5
BMJ Open
553 training papers
6
Neuropsychopharmacology
29 training papers
7
Frontiers in Psychiatry
56 training papers
8
Scientific Reports
701 training papers
9
International Journal of Environmental Research and Public Health
116 training papers
10
PLOS Digital Health
88 training papers
11
Brain Stimulation
27 training papers
12
Translational Psychiatry
94 training papers
13
Journal of Medical Internet Research
81 training papers
14
BMC Medicine
155 training papers